Ignite Creation Date:
2025-12-24 @ 1:36 PM
Ignite Modification Date:
2026-04-21 @ 10:49 PM
Study NCT ID:
NCT02206295
Status:
COMPLETED
Last Update Posted:
2025-02-03
First Post:
2014-07-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study in Healthy Male Subjects to Demonstrate Bioequivalence of 1600 μg Selexipag Administered as Eight Tablets of 200 μg or as Single Tablet of 1600 μg
Sponsor:
Actelion
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AC-065-108
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None